Prognostic value of baseline neutrophil-to-lymphocyte ratio for predicting clinical outcome in metastatic pancreatic ductal adenocarcinoma (mPDAC) patients treated with liposomal irinotecan (nal-IRI)+5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alone

被引：0

作者：

Hubner, R. A. ^{[1
]}

Chen, L-T. ^{[2
]}

Li, C-P. ^{[3
]}

Bodoky, G. ^{[4
]}

Dean, A. ^{[5
]}

Lee, K-H. ^{[6
]}

Cunningham, D. ^{[7
]}

Siveke, J. T. ^{[8
]}

Braiteh, F. S. ^{[9
]}

de Jong, F. A. ^{[10
]}

Belanger, B. ^{[11
]}

Walls, R. ^{[11
]}

Mody, P. D. ^{[11
]}

von Hoff, D. D. ^{[12
]}

Wang-Gillam, A. ^{[13
]}

机构：

[1] Christie NHS Fdn Trust, Oncol, Manchester, Lancs, England

[2] Natl Hlth Res Inst, Oncol, Tainan, Taiwan

[3] Taipei Vet Gen Hosp, Gastroenterol & Hepatol, Taipei, Taiwan

[4] Egyesitett Szent Istvan & Szent Laszlo Korhaz Ren, Oncol, Budapest, Hungary

[5] St John God Hosp, Oncol, Subiaco, WA, Australia

[6] Seoul Natl Univ Hosp, Oncol, Seoul, South Korea

[7] Royal Marsden Hosp NHS Fdn Trust, GI & Lymphoma Res unit, London, England

[8] Univ Hosp Essen, Solid Tumor Translat Oncol, Westdeutsch Tumorzentrum, Essen, Germany

[9] Comprehens Canc Ctr Nevada, Oncol, Las Vegas, NV USA

[10] Shire, Global Med Affairs, Oncol, Zug, Switzerland

[11] Ipsen Biopharmaceut Inc, Med Affairs, Oncol, Basking Ridge, NJ USA

[12] Translat Genom Res Inst, Oncol, Phoenix, AZ USA

[13] Washington Univ, Sch Med, Oncol, St Louis, MO USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

741P

引用

页数：1